Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 5INDUSTRY 2OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Lymphoid 1

Conditions

Mesothelioma, Malignant 1

Interventions

pembrolizumab 2fludarabine 2apatinib 2Interleukin-2 2Cyclophosphamide 2spartalizumab 1phosphorylethanolamine 1olaparib 1liposomal doxorubicin 1ivarmacitinib 1camrelizumab 1anlotinib 1Valproic Acid 1Topotecan 1Talc 1Pharmaceutical Services 1Injections 1Hydralazine 1Cisplatin 1Cerebral Decortication 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × liposomal doxorubicin × Other solid neoplasm × Clear all
NCT00886028 2009-04-22

Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma

National Institute of Cancerología

Phase 2 Unknown
31 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡